Evidence map›Paper›PMID 31088010›Full record

ArticleJournal of ultrasonography2019

Stress echocardiography. Part I: Stress echocardiography in coronary heart disease.

Edyta Płońska-Gościniak, Andrzej Gackowski, Tomasz Kukulski, Jarosław D Kasprzak, Andrzej Szyszka, Wojciech Braksator, Zbigniew Gąsior, Barbara Lichodziejewska, Piotr Pysz

Abstract read
In one paragraph

Article in Journal of ultrasonography, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Edyta Płońska-GościniakDepartment of Cardiology Pomeranian Medical University , Szczecin , Poland.
Andrzej GackowskiDepartment of Coronary Disease and Heart Failure of Jagiellonian University Medical College, Noninvasive Cardiovascular Laboratory, Specialist Hospital in Cracow , Cracow , Poland.
Tomasz KukulskiDepartment of Cardiology, Congenital Heart Diseases and Electrotherapy, The Silesian Center for Heart Diseases in Zabrze, Medical University of Silesia , Zabrze , Poland.
Jarosław D KasprzakDepartment of Cardiology, Medical University of Lodz , Lodz , Poland.
Andrzej SzyszkaDepartment of Cardiology, Poznan University of Medical Sciences , Poznań , Poland.
Wojciech BraksatorDepartment of Sports Cardiology and Noninvasive Cardiac Diagnosis, Medical University of Warsaw , Warsaw , Poland.
Zbigniew GąsiorDepartment of Cardiology, Medical University of Silesia in Katowice , Katowice , Poland.
Barbara LichodziejewskaDepartment of Cardiology, Medical University of Warsaw , Warsaw , Poland.
Piotr PyszDepartment of Cardiology and Structural Heart Diseases, Medical University of Silesia, School of Medicine in Katowice , Poland ; Cardiac Rehabilitation Department Treatment and Rehabilitation Center, Long-Term Care Hospital , Jaworze , Poland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Stress echocardiography (stress echo) is a method in which various stimuli are used to elicit myocardial contractility or provoke cardiac ischemia with simultaneous echocardiographic image acquisition of left ventricular function and valvular flow, if needed. The technique is a well-recognized, safe and widely available stress test used for the diagnosis and assessment of prognosis in coronary heart disease, but may also prove valuable in valvular heart disease. The stressors used include physical exercise, pharmacological agents (dobutamine, vasodilators) and pacing stress, most often with the use of a permanent pacemaker. Two operators should perform the test: a physician experienced in stress echocardiography (at least 100 tests completed under supervision of an expert) and a trained nurse or another doctor. The laboratory should feature a defibrillator and a resuscitation kit with a set of pharmaceuticals, an intubation kit and an AMBU bag. Pacing stress echo requires an external programmer for the implanted permanent pacemaker. Exercise should be the preferred stressor for the diagnosis of ischemic heart disease with alternative of high-dose dobutamine test in cases of contraindications to physical stress. Pacing stress echo is recommended for patients with pacemakers, and dipyridamole test for the assessment of coronary flow reserve. Chest pain in patients with intermediate probability of coronary artery disease, inability to perform physical exercise and non-diagnostic resting or exercise electrocardiography are indications for stress echo. The test is also used in symptomatic patients after revascularization or patients qualified for revascularization for functional assessment of coronary artery stenosis. Low-dose dobutamine test is usually performed in patients after myocardial infarction or with moderate-to-severe left ventricular dysfunction to assess myocardial viability before potential revascularization. Stress echocardiography (stress echo) is a method in which various stimuli are used to elicit myocardial contractility or provoke cardiac ischemia with simultaneous echocardiographic image acquisition of left ventricular function and valvular flow, if needed. The technique is a well-recognized, safe and widely available stress test used for the diagnosis and assessment of prognosis in coronary heart disease, but may also prove valuable in valvular heart disease. The stressors used include physical exercise, pharmacological agents (dobutamine, vasodilators) and pacing stress, most often with the use of a permanent pacemaker. Two operators should perform the test: a physician experienced in stress echocardiography (at least 100 tests completed under supervision of an expert) and a trained nurse or another doctor. The laboratory should feature a defibrillator and a resuscitation kit with a set of pharmaceuticals, an intubation kit and an AMBU bag. Pacing stress echo requires an external programmer for the implanted permanent pacemaker. Exercise should be the preferred stressor for the diagnosis of ischemic heart disease with alternative of high-dose dobutamine test in cases of contraindications to physical stress. Pacing stress echo is recommended for patients with pacemakers, and dipyridamole test for the assessment of coronary flow reserve. Chest pain in patients with intermediate probability of coronary artery disease, inability to perform physical exercise and non-diagnostic resting or exercise electrocardiography are indications for stress echo. The test is also used in symptomatic patients after revascularization or patients qualified for revascularization for functional assessment of coronary artery stenosis. Low-dose dobutamine test is usually performed in patients after myocardial infarction or with moderate-to-severe left ventricular dysfunction to assess myocardial viability before potential revascularization.

Identifiers

PMID31088010
PMCPMC6750176

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.